Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIRALUNG: Effect of liraglutide on lung function in type 2 diabetes mellitus
2014-005125-12Phase 4Completed
- Sponsor
- Dr. Albert Lecube, Ph.D., M.D.
- Start
- Feb 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Dr. Albert Lecube, Ph.D., M.D. Primary endpoint: Forced expiratory volume in one second (FEV1). Started Feb 2016; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-005125-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005125-12.